Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma

2019 
Editorial support was provided by Mike Jaqua, PhD, and AlanSaltzman, PhD, of JK Associates, Inc., and Michael A. Nissen, ELS, ofAstraZeneca. This support was funded by AstraZeneca.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    20
    References
    50
    Citations
    NaN
    KQI
    []